Tscan therapeutics refinances existing convertible debt facility with term loan for up to $52.5 million from silicon valley bank

New non-dilutive structure replaces existing convertible facility maturing in 2026, and extends loan maturity to 2029 new non-dilutive structure replaces existing convertible facility maturing in 2026, and extends loan maturity to 2029

TCRX Ratings Summary

TCRX Quant Ranking